American National Bank Incyte Corp Transaction History

American National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$57.77 - $65.93 $8,954 - $10,219	-155 Reduced 44.16%	196 $11,000
Q1 2023 Apr 25, 2023	SELL	$70.23 - $86.01 $3,581 - $4,386	-51 Reduced 12.69%	351 $25,000
Q4 2022 Jan 10, 2023	SELL	$67.18 - $84.11 $3,224 - $4,037	-48 Reduced 10.67%	402 $32,000
Q3 2022 Oct 05, 2022	BUY	$66.18 - $82.86 $29,781 - $37,287	450 New	450 $30,000

651

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of American National Bank, based on Form 13F filings with the SEC.

Stay updated on American National Bank with notifications on news.